Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer

Pei Wen Wang, Mohammad R. Abedini, Li Xing Yang, Ann Ann Ding, Daniel Figeys, Jang Yang Chang, Benjamin K. Tsang, Dar Bin Shieh

研究成果: 雜誌貢獻文章同行評審

26 引文 斯高帕斯(Scopus)


Chemoresistance is a major challenge in cancer therapy. Cisplatin is commonly used for chemotherapy in patients with head-and- neck cancer (HNC), but it increases control of the disease by only 10-15%. Downregulation of proapoptotic pathways is a key determinant for chemoresistance in which gelsolin (GSN) is critically involved. We analyzed the association between GSN expression and cisplatin resistance in HNC cell lines, animals with HNC and cancer tissue samples from 58 cisplatin-treated patients with HNC. GSN expression levels were positively associated with chemoresistance in vitro and in vivo. Cisplatin-induced GSN downregulation was associated with the cleavage of GSN and the promotion of apoptosis. GSN silencing facilitated cisplatin-induced apoptosis in chemoresistant cells. In contrast, intact gelsolin was prosurvival in the presence of cisplatin by interacting with X-linked inhibitor of apoptosis protein (XIAP). In chemosensitive cells, cisplatin suppressed GSN-XIAP interaction, promoted translocation of XIAP from the perinuclear region to the nucleus and induced apoptosis. In chemoresistant cells, GSN was highly expressed, and cisplatin had no significant effect on GSN-XIAP interaction and apoptosis. We conclude that GSN is important for chemoresistance in HNC and may be an appropriate therapeutic target in chemoresistant cancers.
頁(從 - 到)2760-2769
期刊International Journal of Cancer
出版狀態已發佈 - 12月 2014

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究


深入研究「Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer」主題。共同形成了獨特的指紋。